Merck Half-Year Financial Report Q2_2010 - Merck shares (optimized for printing)

The Merck share price was basically unchanged between the end of the first and the second quarter, moving from EUR 60.00 on March 31 to EUR 59.99 on June 30. The share price high during the second quarter was EUR 64.32, recorded on April 27. The low price for the quarter was EUR 57.65 on May 25. Germany’s DAX Index, of which Merck is a member, fell 3.1% during the second quarter and the Bloomberg Europe Pharmaceuticals Index fell 11%.

Share data¹

XLS

2^nd quarter
2010

1^st quarter
2010

1	Share-price relevant figures relate to the closing price in XETRA trading on the Frankfurt Stock Exchange.
2	The calculation of the theoretical number of shares is based on the fact that the general partner‘s equity capital is not represented by shares. As the share capital of EUR 168.0 million was divided into 64.6 million shares, the corresponding calculation resulted in 152.8 million theoretical shares for the general partner’s capital of EUR 397.2 million on the balance sheet date June 30, 2010.
3	Based on the theoretical number of shares as of June 30, 2010.

Earnings per share after tax and non-controlling interest in EUR

0.84

0.88

Share price high in EUR

(April 27) 64.32

(Jan. 20) 67.67

Share price low in EUR

(May 25) 57.65

(Feb. 25) 57.62

Closing share price in EUR

(June 30) 59.99

(March 31) 60.00

Actual number of shares in millions

64.6

Theoretical number² of shares in millions

217.4

Market capitalization³ in EUR million

13,041

13,043

Merck shares

The performance of Merck shares vs. the DAX®/Bloomberg Europe Pharmaceuticals Index